Kategoriee
Øyedråper
$38.00
Bimat + Applicators
Bimatoprost
Bimatoprost
Bimat eye drops are used for the treatment of a condition called hypotrichosis. This condition causes ...
$35.66
Careprost
Bimatoprost
Bimatoprost
Careprost eye drops is a drug commonly used to lower the intra ocular pressure in patients with glaucoma. ...
$41.50
Careprost + Applicators
Bimatoprost
Bimatoprost
Careprost eye drops 0.03% are widely used to treat hypotrichosis, which is a condition where eyelash ...
$65.17
Lumigan
Bimatoprost
Bimatoprost
Lumigan eyedrops (0.03%) is an ophtalmic solution which helps in treating glaucoma. Glaucoma is a disease ...
$76.00
Lumigan + Applicators
Bimatoprost
Bimatoprost
Lumigan eyedrops are widely used by people all over the globe and also promoted by celebrities because ...
$29.00
Bimatoprost 0.03%
Bimatoprost
Bimatoprost
Bimatoprost is a prostaglandin analog, used mainly to treat glaucoma and ocular hypertension.
$64.80
Xalatan 0.005%
Latanoprost
Latanoprost
Xalatan is used to decrease high pressure in the eye in the patients who have open-angle glaucoma.
Betalingsmåter:
Sikker Betalingsprosess:
Nyheter
'The NHS at its worst', ex-ombudsman tells inquiry
Sir Rob Behrens says it was a "disgrace" how mental health services failed two vulnerable men.
Plan to modernise 1,000 GP practice buildings
The Department of Health and Social Care said it is the biggest public investment in facilities in England in five years.
Swinney vows action on GP appointment 'lottery'
Scotland's first minister says the NHS will be at the heart of his government's plans for the coming year.
Nyheter
Covid-19: Oxford University vaccine shows 70% protection
Other groups have reported higher protection, but the results are still seen as a triumph.
Covid risk: 3 people, 3 very different Covid risks. What's yours?
A question everyone's asking: what's my Covid risk? Here's how to find out.
Coronavirus: £3bn for NHS but Sunak warns of 'economic shock' to come
Borrowing - which hit a record £22.3bn in October - cannot go on indefinitely, chancellor says.